Direct Rx 2023-04-12 Health serious FDA
Health · FDA · Recall #FDA-D-0509-2023
Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct… Recall
Issued April 12, 2023 · Direct Rx
In April 2023, Direct Rx recalled the Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
What you should do
- 1 Stop using Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Direct Rx to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Direct Rx
- Category
- Health
- Recall date
- April 12, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0509-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Direct Rx has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.